Neuropathy News and Research

RSS
IUPUI researcher receives $2.85 million grant to find ways to improve bone strength

IUPUI researcher receives $2.85 million grant to find ways to improve bone strength

Scientists develop new gene therapy that prevents axon destruction in mice

Scientists develop new gene therapy that prevents axon destruction in mice

Using Assay Kits and Dyes to Advance Cell Biology Research

Using Assay Kits and Dyes to Advance Cell Biology Research

Russian scientists create hardware-information system for brain disorders treatment

Russian scientists create hardware-information system for brain disorders treatment

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

Virginia Tech and UC San Diego researchers team up to develop nonopioid drug for chronic pain

Statins associated with low risk of side effects

Statins associated with low risk of side effects

New first-line treatment for peripheral T-cell lymphoma approved by FDA

New first-line treatment for peripheral T-cell lymphoma approved by FDA

Regenerative medicine scientist receives $1.3 million to study stem cell therapy for liver failure

Regenerative medicine scientist receives $1.3 million to study stem cell therapy for liver failure

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Physician-scientists treat first patient in the U.S. with focused ultrasound for neuropathic leg pain

Physician-scientists treat first patient in the U.S. with focused ultrasound for neuropathic leg pain

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Study finds differences in side-effects experienced by male and female OG cancer patients

Study finds differences in side-effects experienced by male and female OG cancer patients

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

Common painkiller not effective in controlling chronic pain after traumatic nerve injury

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients